Overview
Rameda is a leading Egyptian pharmaceutical company engaged in the development and production of a wide range of branded generic pharmaceuticals, nutraceuticals, food supplements and veterinary products. Today, we have an attractive portfolio which includes 129 marketed products relating to 90 molecules, and are predominately focused on twelve therapeutic areas, including systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system and antirheumatic system.
Our headquarters and state-of-the-art production facility are located in 6th of October City in the Giza Governorate west of Cairo. The newly renovated facility features 20 production lines situated in three independent factories, all within the same location, providing the Group with diversified production capabilities. Rameda is led by a strong and experienced senior management team who has driven the business through difficult market conditions and has established a pathway to future growth and success of the business.
Growth drivers
Identify new molecules being marketed in other countries to register and launch in Egypt.
Find accretive opportunities for vertical or horizontal integration through corporate acquisitions that can synergistically leverage Rameda’s existing business segments.
Acquire molecules already registered in Egypt from other Egyptian pharmaceutical companies.